Article3 Biotech2016
Multi-substrate biodegradation of chlorophenols by defined microbial consortium.
Article in 3 Biotech, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Whole-genome sequencing, genome mining, metabolic reconstruction and evolution of pentachlorophenol and other xenobiotic degradation pathways in Bacillus tropicus strain AOA-CPS1.Functional & integrative genomics · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the present study, a defined mixed microbial consortium was investigated for their ability to utilize three different monochlorophenols (MCPs) and 2,4-DCP individually and in the mixture. None of the individual strains were able to utilize 3-CP and 4-CP, but when they were mixed to form defined consortium, they have shown great potential and degradation of high concentration of 3-CP and 4-CP. Spectrophotometric analysis of metabolites during MCPs degradation establishes the presence of 2-chloromaleylacetate. Multi-substrate degradation study of 2,4-DCP in the presence of three MCPs showed the great prospect of microbial consortium for in situ bioremediation. During multi-substrate degradation, the biodegradation rate (mg L
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.